1443 studies found for:    "Hepatitis C"
Show Display Options
Rank Status Study
21 Completed
Has Results
Real-life Surveillance Study of Patients With Chronic Hepatitis C Treated With PegIntron Injector and Rebetol (Study P04538)(COMPLETED)
Conditions: Hepatitis C, Chronic;   Hepatitis C
Interventions: Biological: PegIntron (peginterferon alfa-2b; SCH 54031) injector;   Drug: Rebetol (ribavirin; SCH 18908)
22 Terminated
Has Results
Relapse Rate in Hepatitis C Patients Treated With Peginterferon Alfa-2b Plus Ribavirin in Common Clinical Practice in France (P05484)(Completed)
Conditions: Hepatitis C;   Hepatitis C, Chronic
Interventions: Biological: Peg-IFN alfa-2b;   Drug: Ribavirin
23 Completed Safety and Efficacy of PegIntron and Rebetol Combination Therapy in Patients With Chronic Hepatitis C in Japan (Study P04505)
Conditions: Hepatitis C, Chronic;   Hepatitis C
Interventions: Drug: peginterferon alfa-2b;   Drug: ribavirin
24 Completed
Has Results
Pharmacoeconomic Study Assessing the Cost of Chronic Hepatitis C Treatment With Peginterferon Alfa-2b (PegIntron) and Ribavirin (Rebetol) in the Czech Republic (Study P04588)(COMPLETED)
Conditions: Hepatitis C, Chronic;   Hepatitis C
Interventions: Biological: peginterferon alfa-2b;   Drug: ribavirin
25 Terminated Post-marketing Surveillance of Children With Chronic Hepatitis C Treated With Intron A (Vial or Pen) and Rebetol (Study P04397)(TERMINATED)
Conditions: Hepatitis C, Chronic;   Hepatitis C
Interventions: Biological: IntronA (interferon alfa-2b; SCH 30500);   Drug: Rebetol (ribavirin; SCH 18908)
26 Completed Safety and Efficacy of PegIntron Plus Rebetol in Patients With Chronic Hepatitis C in Japan, Excluding (1) Subjects With HCV Genotype 1 and High Viral Load, and (2) Interferon-naïve Subjects With Low Viral Load (Study P04841)(COMPLETED)
Conditions: Hepatitis C, Chronic;   Hepatitis C
Interventions: Drug: PegIntron (peginterferon alfa-2b; SCH 54031);   Drug: Rebetol (ribavirin; SCH 18908)
27 Completed Study of ABT-267 in Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Infected Subjects
Conditions: Chronic Hepatitis C;   Hepatitis C Virus (HCV)
Interventions: Drug: ABT-267;   Drug: Peginterferon alpha-2a (pegIFN);   Drug: Ribavirin (RBV);   Drug: Placebo
28 Completed A Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ABT-450 With Ritonavir (ABT-450/r) Dosed in Combination With ABT-072 and Ribavirin (RBV)
Conditions: Hepatitis C;   HCV;   Chronic Hepatitis C;   Hepatitis C Genotype 1
Interventions: Drug: ABT-450/r;   Drug: ABT-072;   Drug: ribavirin
29 Completed SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C
Conditions: Hepatitis C, Chronic;   Hepatitis C;   Thrombocytopenia
Interventions: Drug: SB497115;   Other: Placebo
30 Completed Thymosin Plus PEG-Interferon in Hepatitis C Patients With Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin
Conditions: Hepatitis C;   Hepatitis C, Chronic
Interventions: Drug: thymalfasin (thymosin alpha 1);   Drug: PEGinterferon alfa-2a
31 Completed Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin
Conditions: Hepatitis C;   Hepatitis C, Chronic
Interventions: Drug: thymalfasin (thymosin alpha 1) + PEGinterferon alfa-2a;   Drug: placebo + PEGinterferon alfa-2a
32 Unknown  HDV-Interferon in the Treatment of Chronic Hepatitis C Nonresponders and Naive Hepatitis C Patients
Condition: Chronic Hepatitis C
Interventions: Drug: Oral HDV-Interferon + ribavarin;   Drug: Injectable HDV-Interferon + ribavarin
33 Active, not recruiting An Open-label, Single Arm, Phase 2 Study to Evaluate ABT-450/r/ABT-267 and ABT-333 With Ribavirin (RBV) in Adults With Genotype 1 HCV Infection Taking Methadone or Buprenorphine
Conditions: Hepatitis C;   HCV;   Chronic Hepatitis C
Interventions: Drug: ABT-450/r/ABT-267;   Drug: ABT-333;   Drug: Ribovirin (RBV)
34 Recruiting Rapid Hepatitis C Elimination Trial- A Pilot Study of Daclatasvir/Asunaprevir/BMS-791325 With or Without Ribavirin To Treat Hepatitis C Virus
Condition: Hepatitis C
Interventions: Drug: DCV/ASV/BMS-791325;   Drug: DCV/ASV/BMS-791325 + RBV
35 Completed Study of DEB025/Alisporivir Plus Pegylated Interferon alfa2a and Ribavirin and Boceprevir Plus Pegylated Interferon alfa2a and Ribavirin in African American Chronic Hepatitis C Genotype 1 Patients That Have Never Received Treatment for Their Hepatitis C
Conditions: Hepatitis C;   Liver Disease
Interventions: Drug: DEB025 plus peg-IFN alpha 2a and ribavirin fixed duration treatment;   Drug: DEB025 plus peg-IFN alpha 2a and ribavirin response guided treatment duration;   Drug: Boceprevir plus peg-IFN alpha 2a and ribavirin per label response guided treatment
36 Completed An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1)
Condition: Chronic Hepatitis C
Interventions: Drug: Telaprevir;   Drug: Ribavirin;   Drug: Pegylated-Interferon-alfa-2a
37 Completed Safety and Efficacy of the Therapeutic Vaccine GI-5005 Versus Placebo for the Treatment of Chronic Hepatitis C Infection
Condition: Hepatitis C
Intervention: Biological: GI-5005
38 Completed
Has Results
Observational Study Assessing Chronic Hepatitis C Management in Clinical Practice in Italy (Study P05488 AM1)
Conditions: Hepatitis C;   Hepatitis C, Chronic
Interventions: Biological: Peginterferon alfa-2b;   Drug: Ribavirin;   Biological: Peginterferon alfa-2a
39 Completed
Has Results
Efficacy of Pegetron® Redipen™ Treatment and Treatment Compliance of Patients With Chronic Hepatitis C in Canada (P04423)
Conditions: Hepatitis C, Chronic;   Hepatitis C
Interventions: Biological: PegIFN-2b;   Drug: Ribavirin
40 Withdrawn An Observational Study of Patients With Chronic Hepatitis C Undergoing Treatment With PegIntron and Rebetol in Clinical Practice in Belgium (Study P05494)(WITHDRAWN)
Conditions: Hepatitis C, Chronic;   Hepatitis C
Interventions: Biological: PegIntron (peginterferon alfa-2b; SCH 54031);   Drug: Rebetol (ribavirin; SCH 18908)

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years